Skip to main content

Table 3 Association of chronic kidney disease and apo-lipoprotein B in study subjects stratified by age, gender, body mass index and hyperuricemia

From: Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey

Characters

Odds Ratio (95% CIa)

Model 1b

Model 2b

Model 3b

Model 4b

Model 5b

Age Groups

 18–40

1.53 (1.33,1.77)

1.59 (1.37,1.84)

1.50 (1.29,1.75)

1.41 (1.11,1.79)

1.37 (1.08,1.7)

 40–65

1.57 (1.44,1.73)

1.59 (1.37,1.84)

1.51 (1.37,1.66)

1.30 (1.11,1.53)

1.32 (1.12,1.55)

  > 65

1.28 (1.12,1.47)

1.19 (1.03,1.37)

1.14 (0.99,1.33)

1.14 (0.87,1.49)

1.18 (0.90,1.55)

Gender

 Female

2.03 (1.86,2.22)

1.45 (1.32,1.60)

1.36 (1.23,1.50)

1.13 (0.96,1.35)

1.14 (0.96,1.36)

 Male

1.55 (1.42,1.70)

1.49 (1.35,1.65)

1.42 (1.28,1.57)

1.41 (1.20,1.66)

1.41 (1.20,1.67)

Body Mass Index

  < =25

1.79 (1.66,1.94)

1.48 (1.37,1.61)

1.37 (1.25,1.49)

1.15 (0.99,1.34)

1.16 (0.99,1.34)

  > 25

1.74 (1.55,1.94)

1.51 (1.35,1.70)

1.45 (1.28,1.63)

1.60 (1.31,1.96)

1.62 (1.32,1.99)

Hyperuricemia

 Yes

1.43 (1.25,1.64)

1.38 (1.19,1.59)

1.40 (1.21,1.63)

1.50 (1.16,1.93)

1.52 (1.18,1.97)

 No

1.75 (1.63,1.88)

1.42 (1.31,1.45)

1.39 (1.29,1.51)

1.19 (1.04,1.36)

1.19 (1.04,1.37)

  1. aCI Confidence interval
  2. bAdjusted for the same model as Table 2 except the variable that are stratified